Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials. J of Skin [Internet]. 2026 May 11 [cited 2026 May 12];10(3):s772. Available from: https://skin.dermsquared.com/skin/article/view/4229